Cargando…
1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506399/ http://dx.doi.org/10.1016/j.annonc.2020.08.1795 |
| _version_ | 1783585009612881920 |
|---|---|
| author | Cavic, M. Krivokuca, A. Damjanovic-Velickovic, A. Pavlovic, M. Mihajlovic, M. Rakobradovic, J. Boljevic, I. Malisic, E. Tanic, M. Jankovic, R. |
| author_facet | Cavic, M. Krivokuca, A. Damjanovic-Velickovic, A. Pavlovic, M. Mihajlovic, M. Rakobradovic, J. Boljevic, I. Malisic, E. Tanic, M. Jankovic, R. |
| author_sort | Cavic, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75063992020-09-23 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia Cavic, M. Krivokuca, A. Damjanovic-Velickovic, A. Pavlovic, M. Mihajlovic, M. Rakobradovic, J. Boljevic, I. Malisic, E. Tanic, M. Jankovic, R. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506399/ http://dx.doi.org/10.1016/j.annonc.2020.08.1795 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Cavic, M. Krivokuca, A. Damjanovic-Velickovic, A. Pavlovic, M. Mihajlovic, M. Rakobradovic, J. Boljevic, I. Malisic, E. Tanic, M. Jankovic, R. 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia |
| title | 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia |
| title_full | 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia |
| title_fullStr | 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia |
| title_full_unstemmed | 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia |
| title_short | 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia |
| title_sort | 1731p molecular diagnostics for cancer patients and high-risk individuals during the sars-cov-2 pandemic at the institute for oncology and radiology of serbia |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506399/ http://dx.doi.org/10.1016/j.annonc.2020.08.1795 |
| work_keys_str_mv | AT cavicm 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT krivokucaa 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT damjanovicvelickovica 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT pavlovicm 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT mihajlovicm 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT rakobradovicj 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT boljevici 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT malisice 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT tanicm 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia AT jankovicr 1731pmoleculardiagnosticsforcancerpatientsandhighriskindividualsduringthesarscov2pandemicattheinstituteforoncologyandradiologyofserbia |